C/M Capital Partners, Lp - Feb 10, 2025 SCHEDULE 13G Report for Biodexa Pharmaceuticals Plc Ordinary Shares, nominal value 0.00005 GBP per share (BDRX)

Filing Manager
C/M CAPITAL PARTNERS, LP
Reporting Manager
C/M Capital Master Fund, LP
Security
Biodexa Pharmaceuticals Plc Ordinary Shares, nominal value 0.00005 GBP per share
Symbol
BDRX
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G
Date filed
2/18/2025, 04:30 PM
Date of event
Feb 10, 2025
Next filing
May 28, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
C/M Capital Master Fund, LP 0% 0 0 0 /s/ Thomas Walsh By: C/M Global GP, LLC, General Partner, By: Thomas Walsh, Manager
C/M Capital Partners, LP 0% 0 0 0 /s/ Thomas Walsh Thomas Walsh, Partner
Thomas Walsh 0% 0 0 0 /s/ Thomas Walsh Thomas Walsh, Individually
Jonathan Juchno 0% 0 0 0 /s/ Jonathan Juchno Jonathan Juchno, Individually